| Revenue growth | Q2 +15.8% YoY; H1 +16.0% YoY |
|---|---|
| Margins | Q2 EBITDA margin 23.4%, flat YoY; H1 21.5% vs 22.9% |
| Demand visibility | Dombivli infection burden lifted occupancy QoQ |
| Management confidence | Other three hospitals 'in line with expectations' |
Growth
Q2 revenue +15.8% YoY to Rs 436.3 cr; EBITDA +15.9%; PAT -1.7%. H1 revenue +16.0%; H1 PAT -7.4% to Rs 93.9 cr.
Outlook
Expansion to 2,900 beds from 1,700 at ~Rs 1.5 cr/bed; Pune II CY28, Mira-Bhayandar CY29, BKC CY31. No explicit growth guidance.
Risks
Dombivli ramp-up losses (Rs 9.7 cr H1); finance costs +77% YoY; depreciation +33%; H1 occupancy down to 59.5% from 62.2%.
Last quarter's promises, checked
Delivered
- Guided INR2-3cr/mth Dombivli EBITDA loss → Q2 loss INR0.2cr (= BEAT)
Partly delivered
- Guided Dombivli EBITDA breakeven in 1.5-2 yrs → ~200 beds operating, Q2 loss INR0.2cr, breakeven not yet reached (= PARTIAL)
Missed
- Guided INR2-3cr/mth loss (6-9cr/qtr) → Q1 loss INR9.5cr (= MISS)
- Guided ~INR500cr debt, accrual-funded capex, debt only late-cycle → borrowings INR588.8cr (= MISS)
Investor Presentation filed with NSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹256.75
- Market cap
- ₹8,417 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 45.1×Sector 52.0×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Jupiter Life Line Hospitals Debt & Borrowing: ₹500 Cr
Jupiter Life Line Hospitals secured a Rs. 500 Crore term loan from HDFC Bank for capital expenditure, including a Rs. 300 Crore LC sublimit.
- Value
- ₹500.0 Cr